Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peanut skin extract may tame blood sugar spikes after eating

NCT ID NCT07705191

Disease control Sponsor: TCI Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests whether taking peanut skin extract (SugarLock) or white kidney bean extract before a meal can reduce or delay blood sugar spikes in healthy adults. Participants take capsules with water and have their glucose levels monitored continuously for three hours after eating. The goal is to see if these supplements could help manage post-meal blood sugar.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peanut skin extract (SugarLock) and white kidney bean extract
What this could lead to
If effective, these supplements could offer a natural way to manage blood sugar spikes after meals, potentially helping people without diabetes maintain better glucose control.
What could go wrong
This is a small, early study in healthy adults, so results may not apply to people with diabetes. The supplements may have no significant effect on blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older; * Fasting blood glucose level \< 100 mg/dL; * Individuals without type 1 or type 2 diabetes. Exclusion Criteria: * Women who are pregnant, breastfeeding, or planning to become pregnant during the study period; * Individuals with chronic gastrointestinal diseases (such as irritable bowel syndrome \[IBS\], inflammatory bowel disease \[IBD\], chronic diarrhea, celiac disease, short bowel syndrome, ulcers, colorectal cancer, etc.), a history of epilepsy or seizures, psychiatric disorders, malignant tumors, endocrine disorders, liver or kidney disease, or other major organic diseases; * Individuals with a history of gastrointestinal surgery or organ transplantation; * Individuals who have taken medications or supplements affecting blood glucose or insulin within the past three months; * Individuals allergic to peanuts or white kidney beans; * Full-time employees in the same department as the principal investigator, and students directly taught by the principal investigator during the current semester.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood sugar (glucose) control are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood sugar (glucose) control Postprandial glucose

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chang Jung Christian University

    RECRUITING

    Tainan, 711301, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.